FDA issues safety alert on breast implant-associated cancers
The Food and Drug Administration yesterday alerted health care providers and the public to reports of squamous cell carcinoma in scar tissue around breast implants, as well as lymphomas different than those previously associated with breast implants. The agency recommends that health care providers continue to report cancers around breast implants to help it identify and better understand this emerging issue.
Related News Articles
Headline
The Substance Abuse and Mental Health Services Administration announced Sept. 18 that it awarded $42.3 million in grants to states and territories to support…
Headline
The Food and Drug Administration has approved a blood test for detecting Alzheimer’s by Roche and Eli Lilly, according to an announcement Aug. 24 by Roche. The…
Blog
By Rani E. Snyder, President, The John A. Hartford Foundation and Dr. Chris DeRienzo, AHA Chief Physician Executive/President of AHA’s HRET As the U.S.…
Headline
The Department of Health and Human Services Aug. 14 announced that three health systems have signed the agency’s voluntary pledge related to hospital efforts…
Headline
Department of Health and Human Services Secretary Robert F. Kennedy Jr. Aug. 7 declared a public health emergency for Washington state to address the impacts…
Chairperson's File
We all deserve safe, evidence-based healthcare focused on what matters to us as we age. The AHA is working with several partners to ensure it occurs across…